DP-R208 Pharmacokinetic Study

An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of DP-R208 (Candesartan cilexetil 8mg/Rosuvastatin 10mg), a fixed dose combination compared with coadministration of separate constituents in healthy adult volunteers

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

19 year–55 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

BMI 18~30
signed the informed consent form prior to the study participation

Exclusion criteria

Clinically significant disease
Previously donate whole blood within 60 days or component blood within 14 days
Clinically significant allergic disease
Taken IP in other trial within 90 days
An impossible one who participates in clinical trial by investigator's decision including laboratory test result

Treatment and study plan

DP-R208

Drug

Investigational product is prescribed to all of randomized subjects

Candesartan cilexetil

Drug

Investigational product is prescribed to all of randomized subjects

Rosuvastatin

Drug

Investigational product is prescribed to all of randomized subjects

Primary outcomes

Area under the plasma concentration versus time curve (AUC)

Time frame: up to 48 hours post dose
Peak Plasma Concentration (Cmax)

Time frame: up to 48 hours post dose

Sponsors and collaborators

Lead sponsor

Alvogen Korea

Industry

Registry information

Official study title

DP-R208 Pharmacokinetic Study Phase I

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Mar 15, 2016
Registry last updated: Jun 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed